Estudio piloto de prevalencia de infección por Chlamydia trachomatis detectada por PCR en mujeres con parto prematuro en el Instituto Materno Infantil de Bogotá

Mandell GL, Gordon DR, Bennett JE. Mandell, Douglas, and Bennett’s principles and practice of infectious diseases. 6th ed. Philadelphia: Elsevier Churchill Livingstone; 2005.

Datta SD, Sternberg, M, Johnson R et al. Prevalence of chlamydia and gonorrhea in the United States among persons aged 14-39 years, 1999-2000. Program and abstracts of the 15th Annual Meeting of the International Society of Sexually Transmitted Disease Research; 2003 July 27-30; Ottawa, Ontario, Canada. Abstract 349.

King J, Flenady V. Antibiotics for preterm labour with intact membranes. Cochrane Database Syst Rev 2000;(2):CD000246. Update in: Cochrane Database Syst Rev 2002;(4).

Gaitán H, Eslava J, Garzón CD, Rubio JA, Forero J, Valbuena G, et al. Tamizaje de eventos adversos en atención obstétrica y del puerperio en el Instituto Materno Infantil de Bogotá, Colombia. 2002-2003. Rev Colomb Obstet Ginecol 2005;56:18-27.

Rivlin ME, Morrison JC, Grossman JH 3rd. Comparison of pregnancy outcome between treated and untreated women with chlamydial cervicitis. J Miss State Med Assoc 1997;38:404-7.

Fejgin MD, Cohen I, Horvat-Kohlmann M, Charles AG, Luzon A, Samra Z. Chlamydia trachomatis infection during pregnancy: can it cause an intrauterine infection? Isr J Med Sci 1997;33:98-102.

Ngassa PC, Egbe JA. Maternal genital Chlamydia trachomatis infection and the risk of preterm labor. Int J Gynaecol Obstet 1994;47:241-6.

Black CM. Current methods of laboratory diagnosis of Chlamydia trachomatis infections. Clin Microbiol Rev 1997;10:160-84.

Johnson RE, Green TA, Schachter J, Jones RB, Hook EW 3rd, Black CM, et al. Evaluation of nucleic acid amplification tests as reference tests for Chlamydia trachomatis infections in asymptomatic men. J Clin Microbiol 2000;38:4382-6.

Cook RL, Hutchison SL, Ostergaard L, Braithwaite RS, Ness RB. Systematic review: noninvasive testing for Chlamydia trachomatis and Neisseria gonorrohoeae. Ann Inter Med 2005;142:914-25.

WHO, 2001. Global Prevalence and Incidence of Selected Curable Sexually Transmitted Infections: Overview and Estimates. Geneva: WHO.

Fenton KA, Mercer CH, Johnson AM, Byron CL, McManus S, Erens B, et al. Reported sexually transmitted disease clinic attendance and sexually transmitted infections in britain: prevalence, risk factors, and proportionate population burden.

J Infect Dis 2005;191 Suppl 1:S127-38.

Cravioto MdelC, Matamoros O, Villalobos-Zapata Y, Pena O, Garcia-Lara E, Martinez M, et al. Prevalence of anti-Chlamydia trachomatis and anti-Neisseria gonorrhoeae antibodies in Mexican populations. Salud Publica Mex 2003;45 Supp 5:S681-9.

Jones RB, Katz BP, van der Pol B, Caine VA, Batteiger BE, Newhall WJ. Effect of blind passage and multiple sampling on recovery of Chlamydia trachomatis from urogenital specimens. J Clin Microbiol 1986;24:1029-33.

Verkooyen RP, Luijendijk A, Huisman WM, Goessens WH, Kluytmans JA, van Rijsoort-Vos JH, et al. Detection of PCR Inhibitors in cervical specimens by using the AMPLICOR Chlamydia trachomatis assay. J Clin Microbiol 1996;34:3072-4.

Miller WC, Ford CA, Morris M, Handcock MS, Schmitz JL, Hobbs MM, et al. Prevalence of chlamydial and gonococcal infections among young adults in the United States. JAMA 2004;291:2229-36.

Van Bergen J, Götz HM, Richardus JH, Hoebe CJ, Broer J, Coenen AJ; PILOT CT study group. Prevalence of urogenital Chlamydia trachomatis increases significantly with level of urbanisation and suggests targeted screening approaches: results from the first national population based study in the Netherlands. Sex Transm Infect 2005; 81:17-23.

Gencay M, Koskiniemi M, Fellman V, Ammala P, Vaheri A, Puolakkainen M. Chlamydia trachomatis infection in mothers with preterm delivery and in their newborn infants. APMIS 2001;109:636-40.

Ismail MA, Pridjian G, Hibbard JU, Harth C, Moawad AA. Significance of positive cer vical cultures for Chlamydia trachomatis in patients with preterm premature rupture of membranes. Am J Perinatol 1992;9:368-70.

The John Hopkins Study of Cervicitis and Adverse Pregnancy Outcome. Association of Chlamydia trachomatis and Mycoplasma hominis with intrauterine growth retardation and preterm deliver y. Am J Epidemiol 1989;129:1247-57.

Nyari T, Deak J, Nagy E, Vereb I, Kovacs L, Meszaros G, et al. Epidemiological study of Chlamydia trachomatis infection in pregnant women in Hungary. Sex Transm Infect 1998;74:213-5.

Rastogi S, Das B, Salhan S, Mittal A. Effect of treatment for Chlamydia trachomatis during pregnancy. Int J Gynaecol Obstet 2003;80:129-37.

Matthews-Greer JM, McRae KL, LaHaye EB, Jamison RM. Validation of the Roche COBAS Amplicor system for Chlamydia trachomatis. Clin Lab Sci 2001;14:82-4.

Verkooyen RP, Noordhoek GT, Klapper PE, Reid J, Schirm J, Cleator GM, et al. Reliability of nucleic acid amplification methods for detection of Chlamydia trachomatis in urine: results of the first international collaborative quality control study among 96 laboratories. J Clin Microbiol 2003;41:3013-6.

Martin DH, Nsuami M, Schachter J, Hook EW 3rd, Ferrero D, Quinn TC, et al. Use of multiple nucleic acid amplification tests to define the infected-patient “gold standard” in clinical trials of new diagnostic tests for Chlamydia trachomatis. J Clin Microbiol 2004; 42:4749-58.

Mariani SM. Molecular diagnosis of common STDs. Conference Report. Annual Meeting of the American Society of Clinical Pathology. September 18-21, 2003; New Orleans, Louisiana. Medscape Molecular Medicine 2003: 5(2).

Jaschek, G, Gaydos CA, Welsh LE, Quinn TC. Direct detection of Chlamydia trachomatis in urine specimens from symptomatic and asymptomatic men by using a rapid polymerase chain reaction assay. J Clin Microbiol 1993;31:1209-12.

Harindra V, Underhill G, Tobin JM. Screening for genital chlamydia infection: DNA amplification techniques should be the test of choice. Int J STD AIDS 2003;14:723-6.